Melanoma antigen recognition by tumour-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 (Q73293803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Melanoma antigen recognition by tumour-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

T Ramirez-Montagut

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D M Andrews

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Ihara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Pervaiz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Pandolfi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P J Van Den Elsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Waitkus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L A Boyle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Hishii

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J T Kurnick

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

11-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10606959%20AND%20SRC:MED&resulttype=core&format=json

Tumor antigens recognized by T lymphocytes

2 November 2019

cites work

1 reference

12 December 2020

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

12 December 2020

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

1 reference

12 December 2020

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

12 December 2020

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

12 December 2020

Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.

1 reference

12 December 2020

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

1 reference

12 December 2020

Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response

1 reference

12 December 2020

Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas

1 reference

12 December 2020

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma

1 reference

12 December 2020

Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.

1 reference

12 December 2020

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

12 December 2020

In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites

1 reference

12 December 2020

Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines

1 reference

12 December 2020

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

1 reference

12 December 2020

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

12 December 2020

Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions

1 reference

12 December 2020

Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity

1 reference

12 December 2020

Adoptive immunotherapy with interleukin-2 (IL-2) results in diminished IL-2 production by stimulated peripheral blood lymphocytes

1 reference

12 December 2020

Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures

1 reference

12 December 2020

Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition

1 reference

12 December 2020

Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumour reactivity do not share the same TCR V alpha and V beta gene families

1 reference

12 December 2020

DNA sequencing with chain-terminating inhibitors

1 reference

12 December 2020

Long term growth in vitro of human T cell blasts with maintenance of specificity and function

1 reference

12 December 2020

Helper and suppressor-inducer activity of human T cells and their cloned progeny maintained in long-term culture

1 reference

12 December 2020

Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

1 reference

12 December 2020

Functional characterization of T lymphocytes propagated from human lung carcinomas

1 reference

12 December 2020

Functional analysis of T cell subsets and clones in human renal allograft rejection

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

1 reference

12 December 2020

Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma

1 reference

12 December 2020

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma

1 reference

12 December 2020

Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasis

1 reference

12 December 2020

PCR-SSCP: a method for detection of mutations

1 reference

12 December 2020

Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma.

1 reference

12 December 2020

T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer

1 reference

12 December 2020

How sensitive is PCR-SSCP?

1 reference

12 December 2020

T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.

1 reference

12 December 2020

T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis

1 reference

12 December 2020

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

1 reference

12 December 2020

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

12 December 2020

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

1 reference

12 December 2020

T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines

1 reference

12 December 2020

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

12 December 2020

Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy

1 reference

12 December 2020

Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.

1 reference

12 December 2020